Suscribirse

Dual transcriptomic and epigenomic study of reaction severity in peanut-allergic children - 06/04/20

Doi : 10.1016/j.jaci.2019.10.040 
Anh N. Do, PhD a, Corey T. Watson, PhD a, b, Ariella T. Cohain, PhD a, Robert S. Griffin, MD, PhD c, Alexander Grishin, PhD d, Robert A. Wood, MD e, A. Wesley Burks, MD f, Stacie M. Jones, MD g, Amy Scurlock, MD g, Donald Y.M. Leung, MD h, Hugh A. Sampson, MD d, Scott H. Sicherer, MD d, Andrew J. Sharp, PhD a, Eric E. Schadt, PhD a, Supinda Bunyavanich, MD, MPH, MPhil a, d, ⁎
a Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 
b Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Ky 
c Department of Anesthesia, Hospital for Special Surgery, New York, NY 
d Division of Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 
e Department of Pediatrics, Johns Hopkins University, Baltimore, Md 
f Department of Pediatrics, University of North Carolina, Chapel Hill, NC 
g Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children’s Hospital, Little Rock, Ark 
h Department of Pediatrics, National Jewish Health, Denver, Colo 

∗Corresponding author: Supinda Bunyavanich, MD, MPH, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, # 1498, New York, NY 10029.Icahn School of Medicine at Mount Sinai1425 Madison Ave# 1498New YorkNY10029

Abstract

Background

Unexpected allergic reactions to peanut are the most common cause of fatal food-related anaphylaxis. Mechanisms underlying the variable severity of peanut-allergic reactions remain unclear.

Objectives

We sought to expand mechanistic understanding of reaction severity in peanut allergy.

Methods

We performed an integrated transcriptomic and epigenomic study of peanut-allergic children as they reacted in vivo during double-blind, placebo-controlled peanut challenges. We integrated whole-blood transcriptome and CD4+ T-cell epigenome profiles to identify molecular signatures of reaction severity (ie, how severely a peanut-allergic child reacts when exposed to peanut). A threshold-weighted reaction severity score was calculated for each subject based on symptoms experienced during peanut challenge and the eliciting dose. Through linear mixed effects modeling, network construction, and causal mediation analysis, we identified genes, CpGs, and their interactions that mediate reaction severity. Findings were replicated in an independent cohort.

Results

We identified 318 genes with changes in expression during the course of reaction associated with reaction severity, and 203 CpG sites with differential DNA methylation associated with reaction severity. After replicating these findings in an independent cohort, we constructed interaction networks with the identified peanut severity genes and CpGs. These analyses and leukocyte deconvolution highlighted neutrophil-mediated immunity. We identified NFKBIA and ARG1 as hubs in the networks and 3 groups of interacting key node CpGs and peanut severity genes encompassing immune response, chemotaxis, and regulation of macroautophagy. In addition, we found that gene expression of PHACTR1 and ZNF121 causally mediates the association between methylation at corresponding CpGs and reaction severity, suggesting that methylation may serve as an anchor upon which gene expression modulates reaction severity.

Conclusions

Our findings enhance current mechanistic understanding of the genetic and epigenetic architecture of reaction severity in peanut allergy.

El texto completo de este artículo está disponible en PDF.

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Key words : Food allergy, peanut allergy, reaction severity, transcriptome, epigenome, integrated network, causal mediation

Abbreviations used : eCpG, FDR, GO, NF-κB, RNAseq, sIgE, SPT


Esquema


 This study was supported by the National Institutes of Health (grant nos. R01AI118833, U19AI136053, U19AI066738, and U01AI066560) and the Mindich Child Health and Development Institute at Mount Sinai. The project was also supported by National Jewish (grant no. UL1 TR-002535), Mount Sinai (grant no. UL1 TR-000067), University of Arkansas (grant no. UL1 TR-000039), University of North Carolina (grant no. UL1 TR-000083), and Johns Hopkins (grant no. UL1 TR-000424) from the National Center for Research Resources, a component of the National Institutes of Health. The funding bodies had no role in the collection, analysis, or interpretation of data, or the writing of the manuscript.
 Disclosure of potential conflict of interests: The authors declare that they have no relevant conflicts of interests.


© 2019  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 145 - N° 4

P. 1219-1230 - avril 2020 Regresar al número
Artículo precedente Artículo precedente
  • Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression
  • Sören Mucha, Hansjörg Baurecht, Natalija Novak, Elke Rodríguez, Saptarshi Bej, Gabriele Mayr, Hila Emmert, Dora Stölzl, Sascha Gerdes, Eun Suk Jung, Frauke Degenhardt, Matthias Hübenthal, Eva Ellinghaus, Jan Christian Kässens, Lars Wienbrandt, Wolfgang Lieb, Martina Müller-Nurasyid, Melanie Hotze, Nick Dand, Sarah Grosche, Ingo Marenholz, Andreas Arnold, Georg Homuth, Carsten O. Schmidt, Ulrike Wehkamp, Markus M. Nöthen, Per Hoffmann, Lavinia Paternoster, Marie Standl, Early Genetics and Lifecourse Epidemiology (EAGLE) Eczema Consortium, Klaus Bønnelykke, Tarunveer S. Ahluwalia, Hans Bisgaard, Annette Peters, Christian Gieger, Melanie Waldenberger, Holger Schulz, Konstantin Strauch, Thomas Werfel, Young-Ae Lee, Markus Wolfien, Philip Rosenstiel, Olaf Wolkenhauer, Stefan Schreiber, Andre Franke, Stephan Weidinger, David Ellinghaus
| Artículo siguiente Artículo siguiente
  • Defining challenge-proven coexistent nut and sesame seed allergy: A prospective multicenter European study
  • Helen A. Brough, Jean-Christoph Caubet, Angel Mazon, Diab Haddad, Marcel M. Bergmann, Jacqueline Wassenberg, Valentina Panetta, Rosalynd Gourgey, Suzana Radulovic, Maria Nieto, Alexandra F. Santos, Antonio Nieto, Gideon Lack, Philippe A. Eigenmann

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.